Abstract :

Background: It has been shown that SARS-CoV-2 is a multi-systemic virus and can affect number of body systems including the respiratory tract, the gastro-intestinal tract, the liver, the kidney and the nervous system. Despite the high mortality rate, there is little literature on postmortem findings of this unique virus, perhaps due to its highly contagious nature, inadequate information on prevention, and a lack of robust infrastructure for appropriate management of infected cases at various centers throughout the world.

Aim of the study: The aim of the current study was to review and list the main histological changes seen in patients died because of COVID-19.

Methods: A systemic search was carried out including Google Scholar, PubMed, and MEDLINE and the Google search Engine in order to scan all available published articles dealing with histological changes affection the lung in patients with documented COVID-19. The following key words were used to accomplish the search mission: COVID-19, SARS-CoV-2, Lung Histology, Pulmonary Histology, Histopathology. The search was limited to articles written in English language. Any article published between the end of 2019 and the time of initiating the current work was reviewed. The information in the current review is totally based on reviewed articles that are mentioned in the section of references.

Results: The main sources of lung tissues were Whole lung biopsy, Postmortem study, Core needle biopsy and Ultrasound based samples from autopsy. The exudative changes include injury to pneumocytes, congestion of capillaries, giant cell formations, dilation of alveolar ducts, thickening of capillaries, edema of interstitium and formation of hyaline membrane. The proliferative changes include hyperplasia of Type-2 pneumocytes with some reactive atypia with proliferation of myofibroblastic cells leading to granulation tissue formation, thickening of alveolar wall accumulation of alveolar macrophages, interstitial thickening which harbors collections of proliferating fibroblasts together with foci of hemorrhage and lymphocytic infiltration.

Conclusion: The main histopathological changes in lung of patients with COVID-19 can be grouped into three main phases, exudative, proliferative and fibrotic phases in addition to changes involving vascular tissues, bronchi and bronchioles and the main changes are the diffuse alveolar damage seen in exudative and proliferative phases.

---

Keywords :

COVID-19, Histology, Lung.

---

References :

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
2. Amal Talib Al Sa’ady, Zainab Abdulameer Abdulrasol, Ali Fadhil Obaid, Hayder A. Makki Alhindy, Amir S. Al-Mumin. Prevalence of adverse effects from COVID-19 vaccine among Iraqi adults: A retrospective cross-sectional study. Journal of Emergency Medicine, Trauma & Acute Care. 2022(3):6 http://doi.org/10.5339/jemtac.
3. Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600(7889):408-418. doi:10.1038/s41586-021-04188-6
4. Campbell F, Archer B, Laurenson-Schafer H, et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24):2100509. doi:10.2807/1560-7917.ES.2021.26.24.2100509
5. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(7):1470-1477. doi:10.3201/eid2607.200282
6. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ Res. 2020;188:109819. doi:10.1016/j.envres.2020.109819
7. Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int. 2020;139:105730. doi:10.1016/j.envint.2020.105730
8. Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med. 2020;28(2):174-184.
9. Zhou H, Yang J, Zhou C, et al. A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV. Front Med (Lausanne). 2021;8:628370. Published 2021 Dec 7. doi:10.3389/fmed.2021.628370
10. Amer Fadhil Alhaideri, Waleed Azeez Alameedy, Azher Nema Mohammed Al-Agam, Mahir Abdulkadhum Alzughaibi, Hayder Abdul-Amir M. Al-Hindy, Mazin J. Mousa. Hypovitaminosis D is A Biological Vulnerability for Depressive Symptoms in Major Depression at the era of COVID-19 Outbreak. Clinical Schizophrenia & Related Psychoses. 2022; issue 5(In press).
11. Pandey P, Agarwal S, Rajkumar. Lung Pathology in COVID-19: A Systematic Review. Int J Appl Basic Med Res. 2020;10(4):226-233. doi:10.4103/ijabmr.IJABMR_381_20
12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
13. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020;92:491–4.
14. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153:725–33.
15. Tejerina EE, Padilla R, Abril E, Frutos-Vivar F, Ballen A, Rodríguez-Barbero JM, et al. Autopsy-detected diagnostic errors over time in the intensive care unit. Hum Pathol. 2018;76:85–90.
16. Monteiro RAA, Duarte-Neto AN, Silva LFF, Oliveira EP, Filho JT, Santos GAB, et al. Ultrasound-guided minimally invasive autopsies: A protocol for the study of pulmonary and systemic involvement of COVID-19. Clinics. 2020;75:e1972.
17. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19) Preprints. 2020. p. 2020020407. Available from: https://www.preprints.org/manuscript/202002.0407/v1 .
18. Carsana L, Sonzogni A, Nasr A, Rossi R, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20:1135–1140.
19. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198–209.
20. 22 Grimes Z, Bryce C, Sordillo EM, Gordon RE, Reidy J, Paniz Mondolfi AE, et al. Fatal pulmonary thromboembolism in SARS-CoV-2-infection. Cardiovasc Pathol. 2020;48:107227.
21. Buja LM, Wolf D, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. Emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (covid-19): Report of three autopsies from Houston, Texas and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233.
22. Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, Ferraz da Silva LF, Pierre de Oliveira E, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;18:1517–9.
23. Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49:411–7.
24. 26 Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.
25. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33:1007–14.
26. Wichmann D, Sperhake JP, Lütgehetmann M, Steure S, Edler C, Heineman A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020;173:268–277.
27. Bradley BT, Maioli H, Johnson R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet. 2020;396:320–32.
28. Zhang H, Zhou P, Wei Y, Yue H, Wang Y, Hu M, et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med. 2020;172:629–32.
29. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and Cardiac Pathology in Covid-19: TheFirst Autopsy Series from New Orleans. [Last accessed on 2020 Apr 15]; medRxiv. 2020  DOI:10.1101/2020.04.06.20050575.
30. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–4.
31. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773–8.
32. Al-Hindy H., Mousa M., Hashim O. BCG Vaccine in Preventing COVID-19 Epidemic Had to be Reviewed: Correlation does not Imply causation. Australian Journal of Basic and Applied Sciences 2020;14(11):58-63 DOI: 10.22587/ajbas.2020.14.11.6.